Company News
MacroGenics Receives $24.5M Sanofi Milestone
MacroGenics shares rose 1.3% in after‑hours trading after Sanofi triggered a $24.5 million regulatory milestone payment.
The payment follows FDA’s accelerated approval of TZIELD for children 8‑17 with
